Related Experiment Video
Updated: Jan 3, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Anterior chamber angle and intraocular pressure changes after eventless phacoemulsification surgery in
Mohamed Mohamed-Aly Ibrahim1, Omar H Salama2,3
1Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Purpose:
The purpose was to evaluate the angle of the anterior chamber (ACA) and intraocular pressure (IOP) changes following eventless phacoemulsification surgery done for non-glaucomatous Egyptian patients.
Methods:
A prospective, interventional study involved 126 cataractous patients undergoing phacoemulsification with intraocular lens implantation. Patients were investigated for ACA and IOP preoperatively and postoperatively at 1 month and 6 months. Anterior chamber angles were evaluated by Scheimpflug camera, and IOP was measured by Goldmann applanation tonometer.
Results:
A total of 144 eyes from 126 patients were enrolled: 65 males and 79 females; mean age was 59.72 years. At 6 months after phacoemulsification, there was highly significant decrease in IOP (P = 0) and anterior chamber angle (P = 0). The change in IOP did not correlate statistically with patient age, preoperative IOP, preoperative ACA or ACA widening.
Conclusion:
Phacoemulsification reduced significantly IOP which was maintained for 6 months and widened significantly the anterior chamber angle. None of the studied parameters in our study has proved to be a reliable predictive factor to the amount of IOP drop after phacoemulsification.
More Related Videos
04:59Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
Published on: July 7, 2023
05:46Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...